BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23315159)

  • 1. An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance.
    Ahsan SY; Saberwal B; Lambiase PD; Chaubey S; Segal OR; Gopalamurugan AB; McCready J; Rogers DP; Lowe MD; Chow AW
    Europace; 2013 May; 15(5):711-7. PubMed ID: 23315159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success rate of transvenous left ventricular lead implantation for cardiac resynchronisation therapy - recent experience of a single centre.
    Sterliński M; Maciag A; Kowalik I; Lewandowski M; Zajac D; Syska P; Sosnowski C; Labecka A; Kuśmierski K; Pytkowski M; Szwed H
    Kardiol Pol; 2010 Aug; 68(8):903-9. PubMed ID: 20730721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of using a telescoping-support catheter system for left ventricular lead placement on implant success and procedure time of cardiac resynchronization therapy.
    Jackson KP; Hegland DD; Frazier-Mills C; Piccini JP; Koontz JI; Atwater BD; Daubert JP; Worley SJ
    Pacing Clin Electrophysiol; 2013 May; 36(5):553-8. PubMed ID: 23437927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicardial leads in adult cardiac resynchronization therapy recipients: a study on lead performance, durability, and safety.
    Buiten MS; van der Heijden AC; Klautz RJM; Schalij MJ; van Erven L
    Heart Rhythm; 2015 Mar; 12(3):533-539. PubMed ID: 25460170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of leads and patients following robotic epicardial left ventricular lead placement for cardiac resynchronization therapy.
    Kamath GS; Balaram S; Choi A; Kuteyeva O; Garikipati NV; Steinberg JS; Mittal S
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):235-40. PubMed ID: 21029136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Event-free survival following CRT with surgically implanted LV leads versus standard transvenous approach.
    Miller AL; Kramer DB; Lewis EF; Koplan B; Epstein LM; Tedrow U
    Pacing Clin Electrophysiol; 2011 Apr; 34(4):490-500. PubMed ID: 21463344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Cardiac Resynchronization with Epicardial Left Ventricular Lead.
    Chen L; Fu H; Pretorius VG; Yang D; Wiste HJ; Yuan H; Feld GK; Cha YM; Birgersdotter-Green UM
    Pacing Clin Electrophysiol; 2015 Oct; 38(10):1201-9. PubMed ID: 26172535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the right ventricular lead position on response to cardiac resynchronization therapy.
    Khan FZ; Salahshouri P; Duehmke R; Read PA; Pugh PJ; Elsik M; Begley D; Fynn SP; Dutka DP; Virdee MS
    Pacing Clin Electrophysiol; 2011 Apr; 34(4):467-74. PubMed ID: 21208234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy after coronary sinus lead extraction: feasibility and mid-term outcome of transvenous reimplantation in a tertiary referral centre.
    Zucchelli G; Bongiorni MG; Di Cori A; Soldati E; Solarino G; Fabiani I; Segreti L; De Lucia R; Viani S; Coluccia G; Paperini L
    Europace; 2012 Apr; 14(4):515-21. PubMed ID: 22037541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis associated with redo cardiac resynchronization therapy following complete device and lead extraction due to device-related infection.
    Seifert M; Moeller V; Arya A; Schau T; Hoelschermann F; Butter C
    Europace; 2018 May; 20(5):808-815. PubMed ID: 28398556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study.
    Forleo GB; Di Biase L; Panattoni G; Mantica M; Parisi Q; Martino A; Pappalardo A; Sergi D; Tesauro M; Papavasileiou LP; Santini L; Calò L; Tondo C; Natale A; Romeo F
    J Interv Card Electrophysiol; 2015 Jan; 42(1):59-66. PubMed ID: 25504267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy.
    Zecchin M; Proclemer A; Magnani S; Vitali-Serdoz L; Facchin D; Muser D; Nordio A; Barbati G; Puggia I; Sinagra G; Proclemer A
    Europace; 2014 Mar; 16(3):363-71. PubMed ID: 24189477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term performance of the attain model 4193 left ventricular lead.
    Johnson WB; Abraham WT; Young JB; Wheelan K; Smith AL; Chang Y; Brinkman P;
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1111-6. PubMed ID: 19719485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
    Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
    J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of phrenic nerve stimulation in cardiac resynchronization therapy patients: the role of left ventricular lead type and placement site.
    Biffi M; Exner DV; Crossley GH; Ramza B; Coutu B; Tomassoni G; Kranig W; Li S; Kristiansen N; Voss F
    Europace; 2013 Jan; 15(1):77-82. PubMed ID: 22848075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.